Camzyos has the potential to be the first pharmacological therapy for the treatment of oHCM in adolescents, addressing a high unmet need for this populationApplication based on positive results of ...

Lysoway Therapeutics, a biopharmaceutical company developing small-molecule modulators of lysosomal ion channels, today ...

Pesticides. Mycotoxins. Fraudulent Lab Reports. Forged Certificates of Analysis. This Is the State-Licensed Cannabis and Hemp Supply Chain the Courts and DEA Just Handed a Federal Registration Pathway ...

Grants totalling in excess of £2.2M awarded from two industry leading innovation fundsThe new grants will support the development of Laverock’s single-cell and AI powered gene-control platform, ...

Synexis®, LLC, the leader in touchless, continuous pathogen control technology, today announced a strategic collaboration with Midwest Veterinary Supply to bring Synexis DHP® technology to animal ...

Nature-Cide X2 Plus Selected as Preferred All-Natural SolutionAs Customer Demand Trends Toward Natural Pest Control Solutions, Mosquito Authority / Pest Authority Launches Company-Wide Initiative to ...

Independent qualitative KPIs across 48 RCM categories will help healthcare buyers prove platform performance before purchase\, measuring user experience, functional outcomes, workflow execution, ...

Oral and poster presentations span three priority programs in breast, gynecologic, and gastrointestinal cancers, advancing ...

SAN DIEGO, CA / ACCESS Newswire / June 1, 2026 / Revelation Biosciences, Inc. (NASDAQ:REVB) (the "Company" or "Revelation"), a clinical-stage life sciences company developing innovative solutions to ...

FORT LAUDERDALE, FL / ACCESS Newswire / June 1, 2026 / Sunshine Biopharma Inc. (NASDAQ:SBFM) (the "Company"), a leading pharmaceutical company specializing in generic and specialty prescription ...

Focus is on closing DelivMeds AI transaction, driving pharmacy revenue growth and supporting PharmacyChain™, Medical Drones and Health Lives Here progressRecent capital raise provides capital into ...

At the Choose France summit, Stallergenes Greer, a leading player in the treatment of allergies, announced a strategic investment in its Antony site (Hauts-de-Seine), strengthening its longstanding ...